This is a working overview of ACTH analog, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-04-14. Anything still debated is marked as such rather than presented as settled.
Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.
Later generations of the molecule include an N-acetylated form and an amidated form, both marketed online alongside the parent peptide. These variants differ in terminal chemistry and stability, and they are frequently discussed in the same breath even though they have not been compared in controlled trials. Supply outside formal healthcare systems comes largely from laboratories that synthesize peptides to order. Purity and identity of these materials vary widely, and no single body oversees the international trade.
Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.
Semax 是人工设计的七肽，序列为 Met-Glu-His-Phe-Pro-Gly-Pro，骨架取自促肾上腺皮质激素片段 ACTH(4-10)。它于二十世纪八十年代在苏联的分子遗传学研究机构内合成。设计目标是保留该片段与注意力和记忆相关的活性，同时剔除促皮质激素释放等内分泌作用。此后俄罗斯将其登记为药品并进入临床使用。
当时的短肽研究普遍关注能否穿越血脑屏障、在低剂量下产生中枢效应，Semax 属于这一路线。鼻内给药是其主要使用方式，俄语文献报道的适应症涵盖缺血性卒中、短暂性脑缺血发作、认知功能减退以及视神经病变。这些研究大多发表在当地期刊上，样本规模与终点设置同西方试验惯例存在差异，国际同行对其临床证据的强度看法不一。
各国监管态度分化明显。俄罗斯按处方药管理，部分东欧国家留有使用记录；欧盟与美国未批准其作为药物上市，市面流通品通常标注为研究用化学品。身份差异意味着标示含量、纯度与无菌性缺少统一核查。体育领域还牵涉反兴奋剂名录，跨境携带则受目的地药品法规约束。
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic heptapeptide | Analog of an ACTH fragment |
| Amino acid length | Seven residues | Met-Glu-His-Phe-Pro-Gly-Pro |
| Origin | Moscow, 1980s | Institute of Molecular Genetics |
| Approved regions | Russia and some neighboring states | Not cleared in Western markets |
| Common trade names | Multiple national brands | Sold as a nasal formulation |
Semax 是一种人工合成的七肽，氨基酸序列为 Met-Glu-His-Phe-Pro-Gly-Pro，单字母缩写记作 MEHFPGP。它被归类为促肾上腺皮质激素片段 ACTH(4-10) 的结构类似物，但并不天然存在于生物体内。母体片段 ACTH(4-10) 的序列为 Met-Glu-His-Phe-Arg-Trp-Gly，Semax 替换了中间两个残基，并在羧基端延长了 Pro-Gly-Pro 三肽。这种延长被普遍认为能提升分子对肽酶的耐受性。
该化合物于二十世纪八十年代在俄罗斯被开发，相关工作由俄罗斯科学院分子遗传学研究所的研究团队主导。开发目标并非复制 ACTH 的完整激素活性，而是寻找保留其神经作用方向、同时去除促肾上腺皮质激素释放效应的短肽片段。研究记录显示，这一方向促成了多个相关短肽的合成与筛选，而 Semax 是其中被研究最广泛的一个。当地文献常以 Семакс 这一名称指代它。
研究兴趣主要集中在神经营养因子相关的路径上，包括脑源性神经营养因子与神经生长因子的表达变化。部分实验报告称在特定条件下观察到这些因子的水平上升，但具体信号通路和剂量依赖关系仍未完全厘清。多数公开数据来自细胞模型和动物实验，人体对照研究数量有限。因此，该化合物的作用机制在文献中属于活跃讨论，而非已经确立的定论。
Clinical reports describe use in ischaemic stroke, transient ischaemic attack, optic nerve conditions, and cognitive complaints, but most of these studies are small and were conducted in a single region. Systematic reviews have generally described the evidence base as limited in size and variable in methodological quality. Randomised controlled data suitable for international regulatory assessment are scarce. As a result, major treatment guidelines outside Russia do not include the peptide, and interest in it remains largely research-driven rather than routine clinical.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.
Edward Neill Baker (born 29 October 1942) is a New Zealand scientist specialising in protein purification and crystallization and bioinformatics. He is currently a distinguished professor at the University of Auckland.
is the diffusion coefficient of the analyte. According to this equation, the efficiency of separation is only limited by diffusion and is proportional to the strength of the electric field, although practical considerations limit the strength of the electric field to several hundred volts per centimeter. Application of very high potentials (>20-30 kV) may lead to arcing or breakdown of the capillary. Further, application of strong electric fields leads to resistive heating (Joule heating) of the buffer in the capillary. At sufficiently high field strengths, this heating is strong enough that radial temperature gradients can develop within the capillary. Since electrophoretic mobility of ions is generally temperature-dependent (due to both temperature-dependent ionization and solvent viscosity effects), a non-uniform temperature profile results in variation of electrophoretic mobility across the capillary, and a loss of resolution. The onset of significant Joule heating can be determined by constructing an "Ohm's Law plot", wherein the current through the capillary is measured as a function of applied potential. At low fields, the current is proportional to the applied potential (Ohm's Law), whereas at higher fields the current deviates from the straight line as heating results in decreased resistance of the buffer. The best resolution is typically obtained at the maximum field strength for which Joule heating is insignificant (i.e. near the boundary between the linear and nonlinear regimes of the Ohm's Law plot).
=== Overview === The sequence motif discovery process has been well-developed since the 1990s. In particular, most of the existing motif discovery research focuses on DNA motifs. With the advances in high-throughput sequencing, such motif discovery problems are challenged by both the sequence pattern degeneracy issues and the data-intensive computational scalability issues. Process of discovery
Sources: en.wikipedia.org
Covalent modification: Functionalization with carboxyl groups can reduce cellular and pulmonary toxicity by suppressing NLRP3 inflammasome activation and downregulating pro-inflammatory cytokines (e.g., IL-1β, TGF-β1, PDGF-AA). PEGylation, the covalent attachment of polyethylene glycol (PEG), reduces cellular uptake, protein adsorption, oxidative stress, and immune activation, reducing immune recognition and systemic inflammation.
=== 27 July === One person was killed by Russian shelling in Sumy Oblast. Ukrainian drones struck the Olenya air base in Murmansk Oblast, some 1,800 kilometers from the Ukrainian border, damaging two Tu-22M3s. Engels and Dyagilevo airfields were also attacked, along with an oil refinery in Ryazan. Russian air defence claimed to have shot down 12 drones over various oblasts. The Ukrainian 79th Air Assault Brigade again claimed to have repulsed a Russian assault east of Kurakhove, killing 23 Russian soldiers and injuring 29, as well as destroying a tank and two AFVs.
== CLIA Program == In accordance with the CLIA, the CLIA Program sets standards and issues certificates for clinical laboratory testing. CLIA defines a clinical laboratory as any facility which performs laboratory testing on specimens derived from humans for the purpose of providing information for:
Sources: en.wikipedia.org
The (off-label) upper daily limits for other serotonin-reuptake inhibitors used in the treatment of OCD, by analogy, are 400 mg for sertraline, 100 mg for paroxetine, 120 mg for both fluoxetine and citalopram, 60 mg for escitalopram and 300 mg for clomipramine. In any case with fluvoxamine, treatment is generally begun at 50 mg and increased in 50 mg increments every 4 to 7 days until a therapeutic optimum is reached.
== Mechanism of action == Recently, it has been shown that trabectedin blocks DNA binding of the oncogenic transcription factor FUS-CHOP and reverses the transcriptional program in myxoid liposarcoma. By reversing the genetic program created by this transcription factor, trabectedin promotes differentiation and reverses the oncogenic phenotype in these cells. Other than transcriptional interference, the mechanism of action of trabectedin is complex and not completely understood. The compound is known to bind and alkylate DNA at the N2 position of guanine. It is known from in vitro work that this binding occurs in the minor groove, spans approximately three to five base pairs and is most efficient with CGG sequences. Additional favorable binding sequences are TGG, AGC, or GGC. Once bound, this reversible covalent adduct bends DNA toward the major groove, interferes directly with activated transcription, poisons the transcription-coupled nucleotide excision repair complex, promotes degradation of RNA polymerase II, and generates DNA double-strand breaks. In 2024, researchers from ETH Zürich and UNIST determined that abortive transcription-coupled nucleotide excision repair of trabectedin-DNA adducts forms persistent single-strand breaks (SSBs) as the adducts block the second of the two sequential NER incisions. The researchers mapped the 3’-hydroxyl groups of SSBs originating from the first NER incision at trabectedin lesions, recording TC-NER on a genome-wide scale, which resulted in a TC-NER-profiling assay TRABI-Seq.
==== Data annotation and "ghost workers" ==== Beyond hardware, the development of AI models relies on massive amounts of human labour to label data, train algorithms, and moderate content. This work is frequently outsourced to business process outsourcing (BPO) firms operating in the Global South, particularly in countries like Kenya, Ethiopia, and Colombia. These data labourers, often referred to as "ghost workers", operate in what researchers describe as "digital sweatshops". Workers frequently report exploitative conditions, including low pay (sometimes as little as $2 an hour), forced unpaid overtime, and a lack of job security. Furthermore, content moderators are routinely exposed to graphic, violent, and hateful material in order to train AI safety filters. A 2025 Equidem survey of data workers documented widespread psychological harm, including PTSD, anxiety, and depression resulting from this exposure. In the UK, development experts and technology associations have argued that the UK has a responsibility to address these supply chain abuses. The Institute of Development Studies (IDS) has warned that the uncritical use of AI in international development is morally dubious, noting that AI is often built on "stolen data" labelled using the exploited labour of women in low-income countries. The IDS advocates for a "Responsible AI" approach that removes worker exploitation from the supply chain and ensures fair work practices. Furthermore, techUK, the UK's technology trade association, has criticised the UK Government for falling behind on supply chain regulation.
Morgan State awards baccalaureate, master's, and doctorate degrees. Morgan has educated over 100 Fulbright scholars, the most of any HBCU. Morgan is also first among HBCUs in the number of Fulbright-related grants awarded to students, faculty, and administrators. It is one of the 19 schools included on the inaugural Fulbright HBCU Institutional Leaders list. Since instituting the Fulbright program, Morgan State University has trained 144 Fulbright awardees initiating international studies in 43 different countries. Moreover, 51 MSU professors or administrators (none of whom were Morgan graduates) have earned 73 "Senior Fulbright" awards to 42 countries.
Sources: en.wikipedia.org
It originated at the Institute of Molecular Genetics in Moscow during the 1980s. The work was carried out by a Russian research group that specialized in peptide neuropharmacology.
It is registered as a medicine in Russia and has been used clinically there for decades. No regulatory agency in Western Europe or North America has approved it for any indication.
Semax corresponds to the four-to-ten fragment of adrenocorticotropic hormone. Because it omits the first three residues, it lacks the adrenal-stimulating action of the full hormone.
不存在。它是依据 ACTH 的一段序列人工设计的分子，天然蛋白质中找不到与之完全相同的七肽。名称属于研究代号，而非天然物质名。